Abstract
We investigated the prevalence of metabolic syndrome in patients with obstructive sleep apnea syndrome (OSAS) referred to a tertiary university–based medical center. A cross-sectional study of patients with a definite diagnosis of OSAS was performed using new diagnostic criteria for metabolic syndrome that were designed for the Japanese population. Clinical features and comorbidities related to metabolic syndrome were compared between 819 patients with OSAS (719 men and 100 women) and 89 control subjects without OSAS. Metabolic syndrome was significantly more common in the patients with OSAS than in the controls (49.5% vs. 22.0% for men, p<0.01; 32.0% vs. 6.7% for women, p<0.01). Men with OSAS (apnea-hypopnea index [AHI]≥5/h) had a higher risk of metabolic syndrome compared with controls (odds ratio [OR]: 3.47; 95% confidence interval [CI]: 1.84–6.53). There was a significantly increased risk of metabolic syndrome in men with moderate OSAS (AHI: 15–29.9/h) (OR: 2.83; 95% CI: 1.42–5.66) and men with severe OSAS (AHI≥30/h) (OR: 5.09; 95% CI: 2.67–9.71). Women with OSAS (AHI≥5/h) also had an increased risk of metabolic syndrome (OR: 6.59; 95% CI: 1.47–29.38), and the risk was significantly higher in women with severe OSAS (AHI≥30/h) (OR 14.00; 95% CI: 2.93–66.82). Risk factors for metabolic syndrome differed by gender: in men, age, body mass index (BMI), and OSAS (AHI≥15/h) were significantly associated with metabolic syndrome, whereas, in women, BMI was the only risk factor for metabolic syndrome. The increase of metabolic syndrome in Japanese OSAS patients suggests that this patient population is burdened with multiple risk factors for cardiovascular disease.
Similar content being viewed by others
Article PDF
References
Young T, Peppard PE, Gottlieb DJ : Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217–1239.
Banno K, Walld R, Kryger MH : Increasing obesity trends in patients with sleep-disordered breathing referred to a sleep disorders center. J Clin Sleep Med 2005; 1: 364–366.
Shepertycky MR, Al-Barrak M, Kryger MH : Morbidity and mortality in obstructive sleep apnea syndrome 1: effect of treatment on cardiovascular morbidity. Sleep Biol Rhythms 2003; 1: 15–28.
Budhiraja R, Sharief I, Quan SF : Sleep disordered breathing and hypertension. J Clin Sleep Med 2005; 1: 401–404.
Shiomi T, Sasanabe R, Otake K, Hasegawa R, Usui K : Physiopathology and complications of sleep apnea syndrome. Circulatory complications: obesity-related hypertension and obesity-related heart failure with obstructive sleep apnea. Nippon Naika Gakkai Zasshi 2004; 93: 1114–1119 ( in Japanese).
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) : Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, final report). Circulation 2002; 106: 3143–3421.
Landsberg L : Obesity and the insulin resistance syndrome. Hypertens Res 1996; 19 ( Suppl 1): S51–S55.
Kawamoto T, Ishikawa K : Intra-abdominal fat, lipid metabolism and insulin resistance in coronary artery disease. Hypertens Res 1996; 19 ( Suppl 1): S69–S74.
Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese men—the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203–208.
Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP : Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735–741.
American Academy of Sleep Medicine Task Force : Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667–689.
Johns MW : A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–545.
Rechtshaffen A, Kales A ( eds) : A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, UCLA Brain Information Service/Brain Research Institute, 1968.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC : Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H : A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138–1141.
Committee on Evaluation of Diagnostic Standards for Metabolic Syndrome : Definition and diagnostic standards for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794–809 ( in Japanese).
Vgontzas AN, Bixler EO, Chrousos GP : Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9: 211–224.
Oki Y, Shiomi T, Sasanabe R, et al: Multiple cardiovascular risk factors in obstructive sleep apnea syndrome patients and an attempt at lifestyle modification using telemedicine-based education. Psychiatry Clin Neurosci 1999; 53: 311–313.
Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD : Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991; 99: 861–866.
Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M : Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005; 28: 27–34.
Kai H, Kuwahara F, Tokuda K, Imaizumi T : Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res 2005; 28: 483–490.
Staessen JA, Li Y, Thijs L, Wang JG : Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005; 28: 385–407.
Diamond JA, Phillips RA : Hypertensive heart disease. Hypertens Res 2005; 28: 191–202.
Ikeda T, Gomi T, Shibuya Y, et al: Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients. Hypertens Res 2004; 27: 939–946.
Kono S, Kushiro T, Hirata Y, Hamada C, Takahashi A, Yoshida Y : Class of antihypertensive drugs, blood pressure status, and risk of cardiovascular disease in hypertensive patients: a case-control study in Japan. Hypertens Res 2005; 28: 811–817.
Young T, Peppard P, Palta M, et al: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746–1752.
Nieto FJ, Young TB, Lind BK, et al: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community–based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–1836.
Tanigawa T, Tachibana N, Yamagishi K, et al: Relationship between sleep-disordered breathing and blood pressure levels in community-based samples of Japanese men. Hypertens Res 2004; 27: 479–484.
Stoohs RA, Facchini F, Guilleminault C : Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996; 154: 170–174.
Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS : Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670–676.
Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL : Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677–682.
Li J, Thorne LN, Punjabi NM, et al: Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005; 97: 698–706.
Lam JC, Lam B, Lam CL, et al: Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 2005 ( in press).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sasanabe, R., Banno, K., Otake, K. et al. Metabolic Syndrome in Japanese Patients with Obstructive Sleep Apnea Syndrome. Hypertens Res 29, 315–322 (2006). https://doi.org/10.1291/hypres.29.315
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.315
Keywords
This article is cited by
-
Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020
Sleep and Biological Rhythms (2022)
-
Improving obesity and blood pressure
Hypertension Research (2020)
-
Prevalence of Obstructive Sleep Apnoea in Patients with Metabolic Syndrome: A Prospective Observational Study from a Tertiary Care Centre in North India
Sleep and Vigilance (2019)
-
A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea
Sleep and Breathing (2019)
-
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Hypertension Research (2019)